Jonathan I. Lieber

Jon is the Chief Financial Officer of Rallybio. He has more than 30 years of experience as a CFO for public and private life sciences companies and an investment banker. Most recently, he served as the CFO of Applied Genetic Technologies Corporation (AGTC), a publicly traded biotechnology gene therapy company focused on rare diseases, where he led all capital raising activities and was responsible for accounting and finance, human resources, investor relations, information technology and project management. Prior to AGTC, Jon was a Managing Director at Danforth Advisors, a private equity-backed firm, where he provided CFO services and strategic advice to public and private healthcare companies . Previously, he has served as CFO at firms including Histogenics, a publicly traded cell therapy company, Repligen, Xcellerex (acquired by GE Healthcare), and Altus Pharmaceuticals. Jon began his career in healthcare as an investment banker at Salomon Brothers / Salomon Smith Barney and SG Cowen.

Jon is a member of the board of directors of Salarius Pharmaceuticals and serves on the Audit and Nominating and Governance Committees.

Jon earned his Bachelor of Science in business administration and finance from Boston University and a master’s degree in finance from New York University’s Leonard N. Stern School of Business.